Genetic aberrations in soft tissue leiomyosarcoma

Cancer Letters

Volumn 275, Issue 1, 2009, Pages 1-8

  Yang, Jilong ^a   Du, Xiaoling ^a   Chen, Kexin ^a   Ylipää, Antti ^b,c   Lazar, Alexander J F ^b   Trent, Jonathan ^b   Lev, Dina ^b   Pollock, Raphael ^b   Hao, Xishan ^a   Hunt, Kelly ^b   Zhang, Wei ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Array CGH; Genetic alteration; Karyotype; Leiomyosarcoma; Sarcoma

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ALCOHOL DEHYDROGENASE; CALPAIN; CALPAIN 6; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKINE; DEATH ASSOCIATED PROTEIN KINASE; INTERLEUKIN 17B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN MDM2; PROTEIN P16; PROTEIN P53; PROTEOLIPID PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

BLOOD VESSEL; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; KARYOTYPE; LEIOMYOSARCOMA; LIMB; MOLECULAR GENETICS; MUSCLE DEVELOPMENT; NONHUMAN; ONCOGENE; ONCOGENE MYC; PRIORITY JOURNAL; RETROPERITONEUM; SHORT SURVEY; SMOOTH MUSCLE; SOFT TISSUE CANCER; TUMOR SUPPRESSOR GENE; UTERUS SARCOMA;

EID: 58449134800     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.013     Document Type: Review

References (45)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics 2008. CA Cancer J. Clin. 58 (2008) 71-96
2. Fletcher C.D.M., Rydholm A., and Singer S. Soft tissue tumours: epidemiology, clinical features, histopathological typing and grading. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone [M]. first ed. (2002), IARC Press, Lyon, France 12-18
3. de Alava E. Molecular pathology in sarcomas. Clin. Transl. Oncol. 9 (2007) 130-144
4. J.M. Coindre, P. Terrier, L. Guillou, V. Le Doussal, F. Collin, D. Ranchère, X. Sastre, M.O. Vilain, F. Bonichon, N'Guyen Bui B, Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group, Cancer 91 (2001) 1914-1926.
5. Meza-Zepeda L.A., Kresse S.H., Barragan-Polania A.H., Bjerkehagen B., Ohnstad H.O., Namlos H.M., Wang J., Kristiansen B.E., and Myklebost O. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res. 66 (2006) 8984-8993
6. Trent J.C., Lazar A.J., and Zhang W. Molecular approaches to resolve diagnostic dilemmas: the case of gastrointestinal stromal tumor and leiomyosarcoma. Future Oncol. 3 (2007) 629-637
7. Price N.D., Trent J., El-Naggar A.K., Cogdell D., Taylor E., Hunt K.K., Pollock R.E., Hood L., Shmulevich I., and Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc. Natl. Acad. Sci. USA 104 (2007) 3414-3419
8. Evans H.L., and Shipley J. Leiomyosarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone [M]. first ed. (2002), IARC Press, Lyon, France 131-134
9. Wang R., Lu Y.J., Fisher C., Bridge J.A., and Shipley J. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 31 (2001) 54-64
10. El-Rifai W., Sarlomo-Rikala M., Knuutila S., and Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am. J. Pathol. 153 (1998) 985-990
11. Selvarajah S., Yoshimoto M., Prasad M., Shago M., Squire J.A., Zielenska M., and Somers G.R. Characterization of trisomy 8 in pediatric undifferentiated sarcomas using advanced molecular cytogenetic techniques. Cancer Genet. Cytogenet. 174 (2007) 35-41
12. Otaño-Joos M., Mechtersheimer G., Ohl S., Wilgenbus K.K., Scheurlen W., Lehnert T., Willeke F., Otto H.F., Lichter P., and Joos S. Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet. Cell Genet. 90 (2000) 86-92
13. Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin. Cell Dev. Biol. 15 (2004) 171-176
14. Giacinti C., and Giordano A. RB and cell cycle progression. Oncogene 25 (2006) 5220-5227
15. van Dartel M., Leenstra S., Troost D., and Hulsebos T.J. Infrequent but high-level amplification of 17p11.2 approximately p12 in human glioma. Cancer Genet. Cytogenet. 140 (2003) 162-166
16. Henriksen J., Aagesen T.H., Maelandsmo G.M., Lothe R.A., Myklebost O., and Forus A. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. Oncogene 22 (2003) 5358-5361
17. Riva P., Dalprá L., Gualandri V., Volontè M., Miozzo M., Malgara R., Conti A.F., and Larizza L. 19p deletion in recurring leiomyosarcoma lesions from the same patient. Cancer Genet. Cytogenet. 119 (2000) 102-108
18. Pylkkänen L., Sarlomo-Rikala M., Wessman M., Hämäläinen E., Sainio M., Husgafvel-Pursiainen K., and Carpén O. Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors. Hum. Pathol. 34 (2003) 872-879
19. Mertens F., Fletcher C.D., Dal Cin P., De Wever I., Mandahl N., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., Van den Berghe H., Vanni R., and Willén H. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and Morphology. Genes Chromosomes Cancer 22 (1998) 16-25
20. Derré J., Lagacé R., Nicolas A., Mairal A., Chibon F., Coindre J.M., Terrier P., Sastre X., and Aurias A. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab. Invest. 81 (2001) 211-215
21. Dei Tos A.P., Maestro R., Doglioni C., Piccinin S., Libera D.D., Boiocchi M., and Fletcher C.D. Tumor suppressor genes and related molecules in leiomyosarcoma. Am. J. Pathol. 148 (1996) 1037-1045
22. Mandahl N., Fletcher C.D., Dal Cin P., De Wever I., Mertens F., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., Van Den Berghe H., Vanni R., and Willén H. Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. Cancer Genet. Cytogenet. 116 (2000) 66-73
23. Peng H., Yang G.H., Bu H., and Gou L.X. Specific loss of heterozygosity of chromosome 3p loci in soft tissue leiomyosarcoma. Zhonghua Bing Li Xue Za Zhi 32 (2003) 124-127
24. Wang R., Titley J.C., Lu Y.J., Summersgill B.M., Bridge J.A., Fisher C., and Shipley J. Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod. Pathol. 16 (2003) 778-785
25. Wreesmann V.B., and Singh B. Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities. J. Oral Pathol. Med. 34 (2005) 449-459
26. Westra J.L., Plukker J.T., Buys C.H., and Hofstra R.M. Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers. Clin. Colorectal Cancer 4 (2004) 252-259
27. Hu J., Rao U.N., Jasani S., Khanna V., Yaw K., and Surti U. Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet. Cytogenet. 161 (2005) 20-27
28. Larramendy M.L., Kaur S., Svarvar C., Böhling T., and Knuutila S. Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization. Cancer Genet. Cytogenet. 169 (2006) 94-101
29. Pollock R., Lang A., Ge T., Sun D., Tan M., and Yu D. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Clin. Cancer Res. 4 (1998) 1985-1994
30. Kawaguchi K., Oda Y., Saito T., Yamamoto H., Tamiya S., Takahira T., Miyajima K., Iwamoto Y., and Tsuneyoshi M. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. J. Pathol. 201 (2003) 487-495
31. Bialik S., and Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu. Rev. Biochem. 75 (2006) 189-210
32. Kawaguchi K., Oda Y., Saito T., Yamamoto H., Takahira T., Tamiya S., Iwamoto Y., and Tsuneyoshi M. Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. Hum. Pathol. 35 (2004) 1266-1271
33. Vorburger S.A., Hetrakul N., Xia W., Wilson-Heiner M., Mirza N., Pollock R.E., Feig B., Swisher S.G., and Hunt K.K. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol. Cancer Ther. 4 (2005) 1710-1716
34. Skubitz K.M., and Skubitz A.P. Differential gene expression in leiomyosarcoma. Cancer 98 (2003) 1029-1038
35. Ragazzini P., Gamberi G., Pazzaglia L., Serra M., Magagnoli G., Ponticelli F., Ferrari C., Ghinelli C., Alberghini M., Bertoni F., Picci P., and Benassi M.S. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol. Histopathol. 19 (2004) 401-411
36. Shimada S., Ishizawa T., Ishizawa K., Matsumura T., Hasegawa T., and Hirose T. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum. Pathol. 37 (2006) 1123-1129
37. Seidel C., Bartel F., Rastetter M., Bluemke K., Wurl P., Taubert H., and Dammann R. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. Int. J. Cancer 114 (2005) 442-447
38. Kawaguchi K., Oda Y., Saito T., Takahira T., Yamamoto H., Tamiya S., Iwamoto Y., and Tsuneyoshi M. Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas. Hum. Pathol. 36 (2005) 357-363
39. Forus A., D'Angelo A., Henriksen J., Merla G., Maelandsmo G.M., Florenes V.A., Olivieri S., Bjerkehagen B., Meza-Zepeda L.A., del Vecchio Blanco F., Muller C., Sanvito F., Kononen J., Nesland J.M., Fodstad O., Reymond A., Kallioniemi O.P., Arrigoni G., Ballabio A., Myklebost O., and Zollo M. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene 20 (2001) 6881-6890
40. Cho Y.L., Bae S., Koo M.S., Kim K.M., Chun H.J., Kim C.K., Ro D.Y., Kim J.H., Lee C.H., Kim Y.W., and Ahn W.S. Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol. Oncol. 99 (2005) 545-551
41. Wang L., Felix J.C., Lee J.L., Tan P.Y., Tourgeman D.E., O'Meara A.T., and Amezcua C.A. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol. Oncol. 90 (2003) 402-406
42. Ylisaukko-oja S.K., Kiuru M., Lehtonen H.J., Lehtonen R., Pukkala E., Arola J., Launonen V., and Aaltonen L.A. Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients. Int. J. Cancer 119 (2006) 283-287
43. Lehtonen H.J., Kiuru M., Ylisaukko-Oja S.K., Salovaara R., Herva R., Koivisto P.A., Vierimaa O., Aittomäki K., Pukkala E., Launonen V., and Aaltonen L.A. Increased risk of cancer in patients with fumarate hydratase germline mutation. J. Med. Genet. 43 (2006) 523-526
44. Nielsen T.O., West R.B., Linn S.C., Alter O., Knowling M.A., O'Connell J.X., Zhu S., Fero M., Sherlock G., Pollack J.R., Brown P.O., Botstein D., and van de Rijn M. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359 (2002) 1301-1307
45. Baird K., Davis S., Antonescu C.R., Harper U.L., Walker R.L., Chen Y., Glatfelter A.A., Duray P.H., and Meltzer P.S. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res. 65 (2005) 9226-9235